Clinical Trial: A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus Erythematosus

U.S., Aug. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07749430) titled 'A Clinical Study of ACG102 Injection in Patients With Refractory Active Systemic Lupus Erythematosus' on June 05.

Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), immunogenicity, and preliminary efficacy of ACG102 administered via intravenous injection in patients with refractory active systemic lupus erythematosus (SLE)

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Refractory Active Systemic Lupus Erythematosus

Intervention: DRUG: ACG102 Injection

All enrolled participants will receive multiple intravenous infusions of ACG102 at ...